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Abstract
            We describe the unusual occurrence of atrial fibrillation immediately after a seizure in a
young patient with cyclosporine toxicity.  The new onset atrial fibrillation was triggered by
high levels of cyclosporine and possibly facilitated by the electrolyte imbalances post seizure
and the presence of underlying mild left atrial enlargement.
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        A twenty-four year old obese (100 kg) man with a past medical history of pure red cell
aplasia diagnosed 8 months ago was admitted for elective chemotherapy after having failed
outpatient therapy with high dose prednisone and azathioprine.  Upon admission, the patient
was   placed   on   IV   cyclosporine   (12   mg/kg/day  divided   BID)   and   oral   prednisone   (1
mg/kg/day).  On the 3rd hospital day, IV anti-thymocyte globulin (4000 mg/day) infused with
IV  methylprednisolone  (125   mg/day)  was  initiated.   On   the  4th  hospital   day  a  serum
cyclosporine level returned elevated at 995 ng/ml.  At this point the cyclosporine dose was
decreased to 8 mg/kg/day.  He was also transfused 2 units of leukocyte reduced packed red
blood cells for his chronically depressed blood counts (Hemoglobin 6.2 gm/dl). The patient had
an uncomplicated hospital course until the 8th hospital day when he was found in his room
having a tonic-clonic seizure that lasted approximately 1-2 minutes.  Shortly afterwards, he was
found to be in atrial fibrillation with a ventricular rate of 160 bpm and hypotensive with a blood
pressure of 90/50 mmHg.  After a brief postictal period, he denied any complaints but was
aware of his tachycardia.  The patient was initially given a loading dose of dilantin, and his
heart rate was controlled with boluses of IV diltiazem. Laboratory values taken immediately
after his seizure showed a K+ of 3.0 mmol/l, Ca2+ of 6.7 mg/dl, Mg2+ of 1.0 mg/dl, and CO2 of
9 mmol/l, but on repeat labs taken 2 hours later, the electrolyte imbalances had all normalized. 
The patient’s heart rhythm spontaneously converted to normal sinus about 5 hours after he was
initially found to be in atrial fibrillation.  His cyclosporine level that had been drawn just a few
hours prior to his seizure returned as 1360 ng/ml, which is over 4 times the therapeutic dose for
this treatment.   The cyclosporine was held and the following day returned as 264 ng/nl. 
Echocardiogram performed the following day revealed normal systolic function (LVEF 55 –
60%) with a mildly enlarged left atrium (4.2 cm) and mild to moderate tricuspid regurgitation. 
His estimated pulmonary artery pressure was 40 mmHg.
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Fig 1: Electrocardiogram showing atrial fibrillation in a 24 year old man taken immediately
after a witnessed seizure.  His cyclosporine level was toxic at 1360 ng/ml.
 
Fig 2: Electrocardiogram showing normal sinus rhythm taken the following morning after the
initial onset of atrial fibrillation.  The cyclosporine level drawn at this time was 264 ng/ml.
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Discussion
            Although this is not the first time atrial fibrillation has been reported in the literature
from an overdose of cyclosporine1, our case is unusual for the following reasons.  First of all,
our patient received an appropriate dose of cyclosporine but was still found to have toxic levels
of the drug.  While he was given the correct dosages for his weight (12 kg/mg/day), the patient
was obese and some studies suggest that the dosages of cyclosporine in these patients not be
based on their actual body weight 2.  Other potential causes of high blood cyclosporine levels
in this patient are increased gastrointestinal absorption secondary to high dietary fat intake
while in the hospital or an idiosyncratic drug reaction 3.
            What is also unique about this case is that the patient suffered a seizure prior to the
onset of atrial fibrillation.  Seizure is a well described complication of cyclosporine toxicity 4. 
The electrolyte imbalances assumed to be secondary to the seizure may have predisposed the
patient to atrial fibrillation in the face of cyclosporine toxicity.  Although atrial fibrillation is a
known complication of cyclosporine toxicity independent of seizure activity or electrolyte
imbalances, the atrial fibrillation seen in this case occurred at a relatively low level of
cyclosporine toxicity as compared to other case reports in the literature1.   In addition, the
patient may have been at further risk of developing atrial fibrillation due to the mild left atrial
enlargement seen on his echocardiogram. 
Although   the   mechanism   by  which   cyclosporine   causes   atrial   fibrillation   is   unknown,
cyclosporine is known to have some deleterious cardiac effects including coronary vasospasm 5
and ventricular hypertrophy 6.  Further research is needed to determine the mechanisms by
which these potentially harmful cardiac effects occur.
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